A significant number of clinical studies have been devoted to the evaluation of TSPO tracers in MS [28] and showed higher uptake in normal appearing white matter and T2 lesions of MS patients compared to control healthy volunteers [36–38], but limited studies showed correlation with disability (EDSS) [37, 39, 40]. Here, TSPO is linked to myeloid sarcoma.